ZVSA

ZyVersa Therapeutics
ZVSA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZVSA was delisted on the 16th of July, 2025.

Back to rankings

21 hedge funds and large institutions have $55.4M invested in ZyVersa Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.96M
2
+$6.96M
3
+$6.94M
4
CCM
Context Capital Management
California
+$4.97M
5
SCM
Saba Capital Management
New York
+$4.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.96M
2
$6.96M
3
$6.94M
4
$4.97M
5
$4.7M
6
$3.68M
7
$3.47M
8
$3.25M
9
$2.47M
10
$1.98M
11
$1.83M
12
$1.83M
13
$1.76M
14
$1.53M
15
$1.04M
16
$701K
17
$496K
18
$435K
19
$170K
20
$119K
21
$115K